Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors

✍ Scribed by Lynn E. Sullivan; Brent A. Moore; Marek C. Chawarski; Michael V. Pantalon; Declan Barry; Patrick G. O'Connor; Richard S. Schottenfeld; David A. Fiellin

• Book ID: 116696090
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 109 KB
• Volume: 35
• Category: Article
• ISSN: 0740-5472
• DOI: 10.1016/j.jsat.2007.08.004